Acute	acute	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
of	of	O	O	O	O
doxorubicin	doxorubicin	CHEMICALS	O	OTHERS	I
(adriamycin)-loaded	(adriamycin)-loaded	O	O	O	O
cyanoacrylate	cyanoacrylate	O	O	OTHERS	I
nanoparticles	nanoparticles	O	O	O	O
.	.	O	O	O	O

Acute	acute	O	O	O	O
doxorubicin-loaded	doxorubicin-loaded	O	O	O	O
nanoparticle	nanoparticle	O	O	O	O
(	(	O	O	O	O
DXNP	dxnp	O	O	O	O
)	)	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
was	was	O	O	O	O
explored	explored	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
normal	normal	O	O	O	O
rats	rats	O	O	O	O
and	and	O	O	O	O
rats	rats	O	O	O	O
with	with	O	O	O	O
experimental	experimental	O	O	O	O
glomerulonephritis	glomerulonephritis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
normal	normal	O	O	O	O
rats	rats	O	O	O	O
,	,	O	O	O	O
2/6	2/6	O	O	O	O
rats	rats	O	O	O	O
given	given	O	O	O	O
free	free	O	O	O	O
doxorubicin	doxorubicin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
DX	dx	O	O	OTHERS	I
)	)	O	O	O	O
(	(	O	O	O	O
5	5	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
died	died	O	O	O	O
within	within	O	O	O	O
one	one	O	O	O	O
week	week	O	O	O	O
,	,	O	O	O	O
whereas	whereas	O	O	O	O
all	all	O	O	O	O
control	control	O	O	O	O
animals	animals	O	O	O	O
and	and	O	O	O	O
all	all	O	O	O	O
rats	rats	O	O	O	O
having	having	O	O	O	O
received	received	O	O	O	O
free	free	O	O	O	O
NP	np	O	O	O	O
or	or	O	O	O	O
DXNP	dxnp	O	O	O	O
survived	survived	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
3	3	O	O	O	O
times	times	O	O	O	O
higher	higher	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
appeared	appeared	O	O	O	O
in	in	O	O	O	O
animals	animals	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
DXNP	dxnp	O	O	O	O
than	than	O	O	O	O
in	in	O	O	O	O
those	those	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
DX	dx	O	O	OTHERS	I
.	.	O	O	O	O

Free	free	O	O	O	O
NP	np	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
provoke	provoke	O	O	O	O
any	any	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Two	two	O	O	O	O
hr	hr	O	O	O	O
post-injection	post-injection	O	O	O	O
,	,	O	O	O	O
DXNP	dxnp	O	O	O	O
was	was	O	O	O	O
2.7	2.7	O	O	O	O
times	times	O	O	O	O
more	more	O	O	O	O
concentrated	concentrated	O	O	O	O
in	in	O	O	O	O
kidneys	kidneys	O	O	O	O
than	than	O	O	O	O
free	free	O	O	O	O
DX	dx	O	O	OTHERS	I
(	(	O	O	O	O
p	p	O	O	OTHERS	I
<	<	O	O	O	O
0.025	0.025	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
rats	rats	O	O	O	O
with	with	O	O	O	O
immune	immune	O	O	O	O
experimental	experimental	O	O	O	O
glomerulonephritis	glomerulonephritis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
5/6	5/6	O	O	O	O
rats	rats	O	O	O	O
given	given	O	O	O	O
DX	dx	O	O	OTHERS	I
died	died	O	O	O	O
within	within	O	O	O	O
7	7	O	O	O	O
days	days	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
to	to	O	O	O	O
animals	animals	O	O	O	O
treated	treated	O	O	O	O
by	by	O	O	O	O
DXNP	dxnp	O	O	O	O
,	,	O	O	O	O
NP	np	O	O	O	O
,	,	O	O	O	O
or	or	O	O	O	O
untreated	untreated	O	O	O	O
,	,	O	O	O	O
which	which	O	O	O	O
all	all	O	O	O	O
survived	survived	O	O	O	O
.	.	O	O	O	O

Proteinuria	proteinuria	O	DISEASE	OTHERS	I
appeared	appeared	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
series	series	O	O	O	O
,	,	O	O	O	O
but	but	O	O	O	O
was	was	O	O	O	O
2	2	O	O	O	O
-	-	O	O	O	O
5	5	O	O	O	O
times	times	O	O	O	O
more	more	O	O	O	O
intense	intense	O	O	O	O
(	(	O	O	O	O
p	p	O	O	OTHERS	I
>	>	O	O	O	O
0.001	0.001	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
prolonged	prolonged	O	O	O	O
after	after	O	O	O	O
doxorubicin	doxorubicin	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
(	(	O	O	O	O
400	400	O	O	O	O
-	-	O	O	O	O
700	700	O	O	O	O
mg/day	mg/day	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
without	without	O	O	O	O
significant	significant	O	O	O	O
difference	difference	O	O	O	O
between	between	O	O	O	O
DXNP	dxnp	O	O	O	O
and	and	O	O	O	O
DX	dx	O	O	OTHERS	I
.	.	O	O	O	O

Rats	rats	O	O	O	O
treated	treated	O	O	O	O
by	by	O	O	O	O
unloaded	unloaded	O	O	O	O
NP	np	O	O	O	O
behaved	behaved	O	O	O	O
as	as	O	O	O	O
controls	controls	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
results	results	O	O	O	O
demonstrate	demonstrate	O	O	O	O
that	that	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
these	these	O	O	O	O
experimental	experimental	O	O	O	O
conditions	conditions	O	O	O	O
,	,	O	O	O	O
DXNP	dxnp	O	O	O	O
killed	killed	O	O	O	O
less	less	O	O	O	O
animals	animals	O	O	O	O
than	than	O	O	O	O
free	free	O	O	O	O
DX	dx	O	O	OTHERS	I
,	,	O	O	O	O
despite	despite	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
enhanced	enhanced	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
of	of	O	O	O	O
the	the	O	O	O	O
former	former	O	O	O	O
.	.	O	O	O	O

Both	both	O	O	O	O
effects	effects	O	O	O	O
(	(	O	O	O	O
better	better	O	O	O	O
survival	survival	O	O	O	O
and	and	O	O	O	O
nephrosis	nephrosis	O	DISEASE	OTHERS	I
)	)	O	O	O	O
are	are	O	O	O	O
most	most	O	O	O	O
probably	probably	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
an	an	O	O	O	O
enhanced	enhanced	O	O	O	O
capture	capture	O	O	O	O
of	of	O	O	O	O
DXNP	dxnp	O	O	O	O
by	by	O	O	O	O
cells	cells	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
mononuclear	mononuclear	O	O	O	O
phagocyte	phagocyte	O	O	O	O
system	system	O	O	O	O
,	,	O	O	O	O
including	including	O	O	O	O
mesangial	mesangial	O	O	O	O
cells	cells	O	O	O	O
.	.	O	O	O	O

